European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 16, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2026 - 15:45

Human medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2026 - 15:40

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 33, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2026 - 15:34

Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Welireg, belzutifan, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2026 - 15:14

Human medicines European public assessment report (EPAR): Welireg, belzutifan, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan), tenofovir disoproxil, Date of authorisation: 08/12/2016, Revision: 25, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2026 - 15:12

Human medicines European public assessment report (EPAR): Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan), tenofovir disoproxil, Date of authorisation: 08/12/2016, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2026 - 14:50

Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 14 October 2026 - 14:38

Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 14, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness